Naurex
Latest round
- Series C
Last raised
- Dec 2014
Total raised
- $129M
Investors
- 18
About Naurex
Naurex Inc.Naurex Inc. specializes in creating novel therapies for mental health conditions. Founded by Derek Small, the company has its headquarters in Evanston, US., EcoR1 Capital, and Takeda Ventures, along with other undisclosed entities.Naurex Inc. focuses on the development of innovative treatments for psychiatric and neurological disorders. Their leading product candidates aim to address unmet medical needs in areas such as depression, anxiety, and cognitive dysfunction.Naurex generates revenue through strategic partnerships and collaborations with healthcare organizations, focusing on the biopharmaceutical sector. Their revenue model includes product sales directed towards healthcare providers and specialty pharmacies, with an emphasis on addressing both adult and pediatric patient populations.Naurex Inc. The company aims to expand its market reach into Europe and Asia by 2025, capitalizing on strategic partnerships to facilitate entry into these regions. As they continue to innovate, Naurex is positioned to release additional product candidates in the coming years, focusing on enhancing treatment options for patients.
Who invested in Naurex
18 investors across 3 rounds
See all investors in Naurex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Naurex
Who invested in Naurex?
Naurex has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Naurex raised?
Naurex has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Naurex last raise money?
Naurex's most recent round on record is a Series C, in Dec 2014.
What does Naurex do?
Naurex is a biotechnology company.
Where is Naurex headquartered?
Naurex is headquartered in Evanston, US.
Which VCs invest in companies like Naurex?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Naurex's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Naurex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.